AI-based clinical trials solution provider Market Report Delivering Growth Analysis With Key Trends of Top Companies
The global AI-based clinical trials solution provider market size reached USD 1.24 Billion in 2020 and is expected to register a revenue CAGR of 21.5% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of Artificial Intelligence (AI)-enabled digital technology is a key factor driving global AI-based clinical trials solution provider market revenue growth. Increasing use of AI-enabled digital health technologies coupled with patient support platforms is expected to improve patient engagement and retention throughout study duration as well as after study termination, which is expected to propel revenue growth of the global AI-based clinical trial solution provider market.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market
Scope of the Report:
With all the data gathered and analyzed using SWOT analysis,
there was a clearer picture of the competitive landscape of the global AI-based
clinical trials solution provider market. Sources for the future market growth
were uncovered and outlying competitive threats also surfaced. There was
strategic direction eminent in the market and this shows in the key trends and
developments studied. By getting market background and using current norms,
policies, and trends of other leading markets for cross-references, market data
was completed.
Some key players in the market include AiCure, LLC,
Unlearn.AI, Inc., BioAge Labs Inc., Antidote Technologies, Inc., Saama
Technologies Inc., International Machine Business Corporation (IBM), Concentro
Health AI, Deep 6 AI Inc., PathAI Inc., and Owkin Inc.
AI-enabled technologies are enabling data integration and
interpretation along with evolutionary modelling and pattern recognition for
gathering, normalizing, analyzing, and harnessing the growing volumes of data
that fuel modern therapy development. Thus, AI and advanced analytics are
considered as the digital technology that can potentially improve clinical
R&D productivity and clinical outcomes, and this is expected to augment
growth of global AI-based clinical trials solution provider market to a
significant extent.
Emergen Research has segmented the global AI-based clinical
trials solution provider market on the basis of clinical trial phase,
therapeutic application, end-use, and region:
- Clinical
Trial Phase Outlook (Revenue, USD Billion; 2018–2028)
- Phase-I
- Phase-II
- Phase-III
- Therapeutic
Application Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Cardiovascular
Disease
- Neurological
Disease
- Metabolic
Disease
- Infectious
Disease
- Others
- End-use
Outlook (Revenue, USD Billion; 2018–2028)
- Pharmaceuticals
- Academia
- Contract
Research Organizations (CROs)
Important the study on AI-based clinical trials solution
provider market takes a closer look at the top market performers and monitors
the strategies that have enabled them to occupy a strong foothold in the
market. Performance of the product and services across different segments and
geography are thoroughly assessed during the research. Apart from this, the
research brings to light real-time data about opportunities that will completely
transform the trajectory of the business environment in the coming years.
About Us:
At Emergen Research, we believe in advancing with technology. We are a
growing market research and strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially market-disrupting technologies
that are predicted to become more prevalent in the coming decade.
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Comments
Post a Comment